MRKR (STOCKS)
Marker Therapeutics, Inc. Common Stock
$1.110000
-0.050000 (-4.31%)
Prev close: $1.160000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Juan F. Vera
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $18.51M
- Employees
- 5
- P/E (TTM)
- -1.65
- P/B (TTM)
- 1.40
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.16 | $-0.19 | +0.0270 | +14.44% |
|
Dec 2025 (Q4)
|
$-0.09 | $-0.20 | +0.1106 | +55.13% |
|
Sep 2025 (Q3)
|
$-0.12 | $-0.46 | +0.3390 | +73.86% |
|
Jun 2025 (Q2)
|
$-0.29 | $-0.42 | +0.1282 | +30.66% |
Financial Statements
| Revenues | $3.95M |
| Benefits Costs and Expenses | $6.75M |
| Costs And Expenses | $15.24M |
| Operating Expenses | $15.55M |
| Research and Development | $11.51M |
| Other Operating Expenses | $4.05M |
| Operating Income/Loss | -$12.35M |
| Income/Loss From Continuing Operations After Tax | -$10.90M |
| Income/Loss From Continuing Operations Before Tax | -$2.80M |
| Net Income/Loss | -$10.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$10.90M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.61 |
| Diluted Earnings Per Share | -$0.61 |
| Basic Average Shares | 51,378,499 |
| Diluted Average Shares | 51,378,499 |
| Assets | $17.43M |
| Current Assets | $17.43M |
| Noncurrent Assets | $0.00 |
| Liabilities | $3.64M |
| Current Liabilities | $3.64M |
| Accounts Payable | $1.50M |
| Wages | $62.74K |
| Other Current Liabilities | $2.08M |
| Noncurrent Liabilities | $0.00 |
| Equity | $13.80M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $13.80M |
| Liabilities And Equity | $17.43M |
| Net Cash Flow From Operating Activities | -$7.92M |
| Net Cash Flow From Operating Activities, Continuing | -$7.92M |
| Net Cash Flow | -$1.40M |
| Net Cash Flow, Continuing | -$1.40M |
| Comprehensive Income/Loss | -$10.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$10.90M |
| Other Comprehensive Income/Loss | $0.00 |